Making Science Group (MAKS) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
15 Jun, 2026Executive summary
Q1 2026 revenue reached €97.2M, up 20% year-over-year, with gross margin of €17.3M, up 9.5%, and recurring EBITDA up 8.5% to €3.3M; international expansion and AI adoption drove growth.
The company operates four business lines: Digital Agency, Awake/AWAKE, Raising/RAISING, and Investments, with a new segment structure from 2026.
Strategic focus on profitability, cash flow, debt reduction, and operational efficiency, leveraging AI to enhance productivity and reduce headcount to 850 post-divestment.
Dividend of €2M paid in April 2026, charged to 2025 results.
Financial highlights
Consolidated Q1 2026 revenue rose 20% year-over-year to €97.2M; gross margin up 9.5% to €17.3M; recurrent EBITDA up 8.5% to €3.3M.
Operating costs increased 9.6% year-over-year, mainly due to geographic expansion, technology investment, and higher administrative expenses.
Personnel expenses rose 3.6%, reflecting productivity gains from AI adoption.
Dividend of €2M paid in April 2026, equivalent to €0.2222 gross per share.
Outlook and guidance
2026 expected to deliver profitable, sustained growth, leveraging 2025 investments and ongoing efficiency initiatives.
AI products and internal efficiency initiatives to drive organic growth and operational optimization.
Continued international expansion supported by strong financial capacity and cost optimization.
Latest events from Making Science Group
- Strong growth, AI innovation, and global expansion drive leadership in digital acceleration.MAKS
Investor day 2026 presentation17 May 2026 - FY 2025 revenue rose 36% to €374M, EBITDA stable, net debt down 78%, focus shifts to digital and AI.MAKS
Q4 202516 Mar 2026 - H1 2025 revenue up 40% to €174.6M, recurring EBITDA €7.7M, international share at 60%.MAKS
Q2 20252 Nov 2025 - Recurring EBITDA nearly doubled in H1 2024, led by strong Spain and international growth.MAKS
Q2 202411 Jul 2025 - Recurring EBITDA up 94% to €10.6M in 9M24, with robust growth and margin expansion.MAKS
Q3 202411 Jul 2025 - 2024 saw 16% revenue growth and 71% EBITDA surge, with strong international momentum.MAKS
Q4 202411 Jul 2025 - Record Q1 2025 EBITDA and 33% revenue growth driven by strong international expansion.MAKS
Q1 202511 Jul 2025 - Record Q1 2025 EBITDA and rapid international growth highlight strong execution and AI-driven strategy.MAKS
Investor Presentation11 Jul 2025